デフォルト表紙
市場調査レポート
商品コード
1565711

ペン型注入器市場:タイプ別、療法別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測

Injection Pen Market, By Type, By Therapy, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 301 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ペン型注入器市場:タイプ別、療法別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年~2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

ペン型注入器の市場規模は2023年に399億8,033万米ドルとなり、2024年から2032年にかけてCAGR 7.90%で拡大

ペン型注入器市場-市場力学

慢性疾患の増加と生物製剤の需要が市場需要を促進する見込み

主な要因の一つは、定期的なインスリン注射を必要とする糖尿病患者の世界の増加です。国際糖尿病連合は、世界中で数百万人の患者がいると推定しており、インスリンペン型注入器の需要増につながっています。関節リウマチ、多発性硬化症、乾癬のようないくつかの疾患も、ペン型注入器で頻繁に投与される生物学的療法に依存しています。このように、生物学的療法に対するニーズの高まりも市場の成長を後押ししています。

生物学的製剤は、がん、自己免疫疾患、希少遺伝性疾患などの症状に対してますます使用されるようになっています。これらの薬剤の多くはペン型注入器で投与されます。また、生物学的製剤のようなバイオシミラーの台頭は、より費用対効果の高い選択肢が利用できるようになり、ペン型注入器市場の成長を拡大しています。慢性疾患や利用可能な治療法、特に糖尿病管理に関する認識を高めることを目的とした支援策が、ペン型注入器の採用拡大に寄与しています。FDAやEMAのような規制機関は、ペン型注入器の送達に依存する生物学的製剤の承認数を増やしています。また、製薬企業は研究開発に投資しており、新製品の発売によって市場はさらに拡大しています。

ペン型注入器市場-主な洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間(2024-2032年)に約7.90%のCAGRで毎年成長すると予測されています。

タイプ別セグメンテーションでは、使いやすさと利便性から使い捨てタイプが2023年に最大市場シェアを示すと予測されています。

療法のセグメンテーションに基づくと、糖尿病の高い有病率により、糖尿病療法のセグメントが2023年に主要セラピーの座を占めました。

エンドユーザー別では、慢性疾患の臨床・病院治療におけるペン型注入器の需要の高さから、病院・診療所が2023年の主要エンドユーザーでした。

地域別では、北米が2023年の主要収益源でした。これは、意識の高まりと政府の支援策によるものです。

ペン型注入器市場-セグメンテーション分析:

ペン型注入器の世界市場は、タイプ、治療法、エンドユーザー、地域によって区分されます。

タイプ別では、ディスポーザブルとリユーザブルに分けられます。ディスポーザブルセグメントが市場を独占しています。再利用可能なセグメントは、生物製剤の持続可能性が重視されるようになり、このセグメントの成長に拍車をかけているため、大きな伸びを示すと推定されます。

市場は治療法に基づき、糖尿病治療、骨粗鬆症、肥満、不妊、その他の5つのカテゴリーに分類されます。糖尿病治療分野が市場を独占しています。北米とアジア太平洋地域では、最近、糖尿病患者が大幅に増加しており、これが市場の成長を大きく補っています。

市場はエンドユーザー別に病院・診療所、在宅医療、その他の3つに分類されます。病院・診療所セグメントは市場を独占しており、予測期間中も高い優位性を維持すると予想されます。ペン型注入器は、糖尿病や関節炎などの慢性疾患の診断に広く使用されており、同分野の成長に拍車をかけています。

ペン型注入器市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカの地域に広がっています。北米は世界のペン型注入器市場で最大のシェアを占めています。北米は糖尿病、関節炎、その他注射薬を必要とする慢性疾患の発生率が高いです。米国疾病予防管理センター(CDC)の報告によると、米国では数百万人の成人がこれらの疾患を抱えて生活しています。アジア太平洋では、特に中国やインドのような国々で糖尿病や自己免疫疾患の患者が大幅に増加しています。IDFは、中国とインドを合わせると世界の糖尿病患者の3分の1以上を占めると推定しています。

ペン型注入器市場-競合情勢:

注射器市場は競争が激しく、大小の市場プレーヤーで構成されています。企業はハイテク企業と協力してスマートペン機能を強化し、追跡やリマインダーを可能にしています。複数の新規企業や新興企業が新しい注射器具のFDA承認取得を目指しており、市場力学に大きな影響を与える可能性があります。このように、患者中心の設計とデジタルヘルス統合に焦点を当てた革新的なソリューションの開発が進むにつれて、市場は成長を続けると予想されます。

2024年6月、ノボ・ノルディスクは英国市場でノボペンエコー、ノボペン6と呼ばれるスマートインスリンペンを発売しました。

2024年4月、イーライリリー・アンド・カンパニーがネクサス・ファーマシューティカルズの製造施設を買収し、事業範囲を拡大。

目次

第1章 ペン型注入器市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 ペン型注入器の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 ペン型注入器産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 ペン型注入器市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 ペン型注入器市場情勢

  • ペン型注入器市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 ペン型注入器市場- タイプ別

  • 概要
    • セグメントシェア分析
    • 使い捨て
    • 再利用可能

第8章 ペン型注入器市場- 療法別

  • 概要
    • セグメントシェア分析
    • 糖尿病治療
    • 骨粗鬆症
    • 肥満
    • 生殖能力
    • その他

第9章 ペン型注入器市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院・クリニック
    • 在宅ケア環境
    • その他

第10章 ペン型注入器市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- ペン型注入器業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Novo Nordisk
    • Sanofi
    • Eli Lilly
    • Bayer
    • Amgen
    • Merck &Co.
    • AbbVie
    • Boehringer Ingelheim
    • GlaxoSmithKline
    • Johnson &Johnson
    • Viatris
    • Roche
    • Pfizer
    • AstraZeneca
    • Medtronic plc
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV3915

REPORT HIGHLIGHT

Injection Pen Market size was valued at USD 39,980.33 Million in 2023, expanding at a CAGR of 7.90% from 2024 to 2032.

An injection pen is a medical device used to deliver medication via a needle. It is made for ease of use, often by patients themselves, and typically contains a pre-measured dose of medication. Injection pens are commonly used for the treatment of chronic conditions like diabetes, where insulin is administered, or for conditions that require frequent injections such as multiple sclerosis, rheumatoid arthritis, and certain allergies.

Injection Pen Market- Market Dynamics

Rising prevalence of chronic disorders and demand for biologics is expected to propel market demand

One of the major drivers is the global increase in diabetes cases, requiring regular insulin injections. The International Diabetes Federation estimates millions of cases worldwide, leading to higher demand for insulin injection pens. Several conditions like rheumatoid arthritis, multiple sclerosis, and psoriasis also rely on biologic therapies that are frequently administered via injection pens. Thus, increasing need for biological therapies is also boosting market growth.

Biologic drugs are being increasingly used for conditions like cancer, autoimmune diseases, and rare genetic disorders. Many of these medications are administered via injection pens. Also, the rise of biosimilars like biologic drugs is expanding the injection pen market growth as more cost-effective options become available. Supportive initiatives aimed at increasing awareness about chronic diseases and available treatments, particularly diabetes management, have contributed to the increased adoption of injection pens. Regulatory bodies like the FDA and EMA have been approving an increasing number of biologic therapies that rely on injection pen delivery. Additionally, pharmaceutical companies are investing in research and development, leading to new product launches that further expand the market.

Injection Pen Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.90% over the forecast period (2024-2032)

Based on Type segmentation, the disposables segment was predicted to show maximum market share in the year 2023, owing to their ease of use & convenience.

Based on Therapy segmentation, diabetes therapy segment was the leading Therapy in 2023, due to high prevalence of diabetes.

Based on End User segmentation, hospital & clinics segment was the leading End User segment in 2023, due to high demand for Injection Pens in clinical & hospital treatment in chronic diseases.

On the basis of region, North America was the leading revenue generator in 2023, due to the rising awareness and supportive government initiatives.

Injection Pen Market- Segmentation Analysis:

The Global Injection Pen Market is segmented on the basis of Type, Therapy, End User, and Region.

The market is divided into two categories based on Type: disposable and reusable. The disposables segment dominates the market. The reusable segment is estimated to grow at a significant rate as rising emphasis in sustainability in biologics is fueling segment growth.

The market is divided into five categories based on Therapy: diabetes therapy, osteoporosis, obesity, fertility, and others. The diabetes therapy segment dominates the market. In North America and Asia Pacific, recently there has been a significant rise in diabetes patients which is majorly supplementing market growth.

The market is divided into three categories based on End User: hospital & clinics, home-care settings, and others. The hospital & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. Injection pen devices are widely used for diagnosis of chronic disorders like diabetes and arthritis which spur segment growth.

Injection Pen Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds the largest market share in the global injection pen market. North America has a high incidence of diabetes, arthritis, and other chronic conditions that require injectable medications. The Centers for Disease Control and Prevention (CDC) reports millions of adults in the U.S. live with these conditions. Asia Pacific has seen a significant increase in cases of diabetes and autoimmune diseases, especially in countries like China and India. The IDF estimates that China and India together account for over one-third of global diabetes cases.

Injection Pen Market- Competitive Landscape:

The Injection Pen market is significantly competitive and made up of small & large sized market players. Companies are collaborating with tech firms to enhance smart pen features, enabling tracking and reminders. Several new companies and startups are looking to gain FDA approvals for new injection devices, which can significantly impact market dynamics. Thus, the market is expected to continue growing as more innovative solutions are developed, focusing on patient-centric designs and digital health integration.

In June 2024, Novo Nordisk launched smart insulin pens called NovoPen Echo, Novo Pen 6 in the UK market.

In April 2024, Eli Lily & Company acquired the manufacturing facility of Nexus Pharmaceuticals to expand their reach.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INJECTION PEN MARKET KEY PLAYERS

  • Novo Nordisk
  • Sanofi
  • Eli Lilly
  • Bayer
  • Amgen
  • Merck & Co.
  • AbbVie
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Johnson & Johnson
  • Viatris
  • Roche
  • Pfizer
  • AstraZeneca
  • Medtronic plc
  • Others

GLOBAL INJECTION PEN MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Disposable
  • Reusable

GLOBAL INJECTION PEN MARKET, BY THERAPY- MARKET ANALYSIS, 2019-2032

  • Diabetes therapy
  • Osteoporosis
  • Obesity
  • Fertility
  • Others

GLOBAL INJECTION PEN MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital & Clinics
  • Home-care settings
  • Others

GLOBAL INJECTION PEN MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Injection Pen Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Injection Pen Market Snippet by Type
    • 2.1.2. Injection Pen Market Snippet by Therapy
    • 2.1.3. Injection Pen Market Snippet by End User
    • 2.1.4. Injection Pen Market Snippet by Country
    • 2.1.5. Injection Pen Market Snippet by Region
  • 2.2. Competitive Insights

3. Injection Pen Key Market Trends

  • 3.1. Injection Pen Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Injection Pen Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Injection Pen Market Opportunities
  • 3.4. Injection Pen Market Future Trends

4. Injection Pen Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Injection Pen Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Injection Pen Market Landscape

  • 6.1. Injection Pen Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Injection Pen Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Disposable
    • 7.1.3. Reusable

8. Injection Pen Market - By Therapy

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapy, 2024 & 2032 (%)
    • 8.1.2. Diabetes therapy
    • 8.1.3. Osteoporosis
    • 8.1.4. Obesity
    • 8.1.5. Fertility
    • 8.1.6. Others

9. Injection Pen Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital & Clinics
    • 9.1.3. Home-care settings
    • 9.1.4. Others

10. Injection Pen Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Injection Pen Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Injection Pen Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Injection Pen Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Injection Pen Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Injection Pen Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Injection Pen Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Novo Nordisk
    • 11.2.2. Sanofi
    • 11.2.3. Eli Lilly
    • 11.2.4. Bayer
    • 11.2.5. Amgen
    • 11.2.6. Merck & Co.
    • 11.2.7. AbbVie
    • 11.2.8. Boehringer Ingelheim
    • 11.2.9. GlaxoSmithKline
    • 11.2.10. Johnson & Johnson
    • 11.2.11. Viatris
    • 11.2.12. Roche
    • 11.2.13. Pfizer
    • 11.2.14. AstraZeneca
    • 11.2.15. Medtronic plc
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us